Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Inovytec specializes in providing advanced, state-of-the-art, non-invasive critical care devices for Pre-hospital and Out of Hospital use, by professional and non-professional caregivers under emergency conditions. Inovytec products are molded to address the 21st Century emergency care expectations, where reliable, fail-safe, and simple to use emergency care will be immediately available for use on-site with the highest assurance of success.

Alloksys Life Sciences BV provides therapies services. It offers Phase 3 clinical trials leading to registration of RESCAP (RESCuing Alkaline Phosphatase) for the prevention and treatment of ischemic injury and inflammation mediated complications in cardiothoracic surgery (APPIRED III). The company was founded by Ruud Brands in 2005 and is headquartered in Wageningen, the Netherlands.

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Beijing AK Medical Co., Ltd. offers orthopedic products and services. The firm provides surgical instruments and orthopedic products. Beijing AK Medical was founded in May 2003 and is headquartered in Beijing, China.

Part of CSL Ltd., CSL Behring GmbH is a German company located in Marburg. The firm manufactures plasma protein bio therapeutics for the treatment of rare and major diseases. Michael Schröder, Lutz Guenter Bonacker and Craig Shelanskey are the current co-CEOs of the firm.

Weinberg Medical Physics is a medical device incubator developing novel medical imaging and interventional technologies that mature into self-sustaining start-ups. They provide rapid high-resolution images, and when combined with their low-power electro-permanent magnets, the system can be installed in dentistry, oncology, and urology practices.

Ningbo Baoting Biotechnology Co., Ltd., established on 2018-01-22, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Special Equipment Sales;internet sales(Except for products that require a license for sale);Import and export;Business Management Consulting;Technology Import and Export;Wholesale of protective equipment for medical staff;Production of protective equipment for medical personnel(Ι class medical device)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices;Drug Wholesale;food sales;Production of protective equipment for medical personnel(Class II medical device)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Biomedica is a research and development company that fosters the development of critical technologies. Its research program began in 1999 with a partnership set up to bridge the funding gap that exists between science and business. The partnership included leading scientists in the field of fibrinogen biochemistry, immunology, polymer chemistry, and trauma surgery. Biomedica Management Corporation is a clinical-stage federally funded research and development company. The company operates under an innovative business model that fosters the development of critical technologies with the vision of academic scientists. Biomedica brings to the market affordable and effective technologies targeting unmet needs in coagulopathic-related conditions, inflammation, and wound healing. Biomedica is headquartered at the UMBC TechCenter in Baltimore, Maryland.,

BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. Simply stated, their mission is to develop and commercialize products that make a dramatic improvement in people's lives. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. The company is headquartered in Indianapolis, IN.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Shandong Dongda High-tech Huatai Pharmaceutical Co., Ltd., established on 1992-07-23, Business scope includes production,Sales:Freeze-dried powder injection,small volume injection,API(The validity period is subject to the license),food,Healthy food;Biotechnology R&D;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Advanced Tactile Imaging is engaged in the business of developing and marketing innovative products for imaging of tissue elasticity which is highly sensitive to changes of physiological and pathological conditions. Our initial patented product, Vaginal Tactile Imager, enables imaging and delivers essential information about the vagina and pelvic floor support structures. We target product launch in 82 countries in 2013-14. Details at: http://www.tactile-imaging.com

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production and sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. It provides blood tumors, gynecology, pediatrics, skin and orthopedic drugs; phosphate buffered saline and polyvinyl butyral products; vitamin B5; and original B5. The company was founded on November 10, 2000 and is headquartered in Hangzhou, China.

Banyan Biomarkers was founded in 2002 by Ron Hayes, PhD , Kevin Wang, PhD, and Nancy Denslow, PhD to create the first Point of Care (POC) Blood Test to diagnose traumatic brain injury (TBI). Currently no blood test exists for use by physicians to detect the presence and severity of brain trauma. Banyan Biomarkers’ research has identified unique and proprietary biomarkers present in the patient’s blood following injury to the brain. The detection and quantification of these biomarkers may provide early indications of brain trauma essential for earlier intervention and management.